BioAlliance Pharma http://http://www.bioalliancepharma.com/eng 10 March 2010 - BioAlliance announces positive preliminary results in the first Phase I clinical trial of fentanyl Lauriad® http://http://www.bioalliancepharma.com/eng/content/download/6138/69518/version/1/file/100310EN_FentanylLauriad.pdf 03 March 2010 - Full-year accounts for 2009 http://http://www.bioalliancepharma.com/eng/content/download/6081/68874/version/1/file/100303EN_Comptes annuels 2009.pdf 09 February 2010 - BioAlliance Pharma announces its consolidated turnover for 2009 - A doubling in recurring revenues http://http://www.bioalliancepharma.com/eng/content/download/5883/66411/version/1/file/100209EN_CA2009.pdf 22 December 2009 - BioAlliance Pharma publishes its 2010 financial calendar http://http://www.bioalliancepharma.com/eng/content/download/5443/61014/version/1/file/091222EN_CalendrierFinancier2010.pdf 15 December 2009 - Entry into clinical phase: clonidine Lauriad® into phase II and AMEPTM into phase I. With fentanyl Lauriad®, three products entered clinical phase in 2009. http://http://www.bioalliancepharma.com/eng/content/download/5397/60439/version/1/file/091215EN_Clonidine_Amep.pdf 10 December 2009 - Breakthrough positive phase III results with acyclovir Lauriad® - Primary and secondary endpoints met – Final results http://http://www.bioalliancepharma.com/eng/content/download/5352/59895/version/1/file/091210EN_Acyclovir.pdf 08 December 2009 - Doxorubicin Transdrug®: Significant increased survival rate in patients with advanced hepatocellular carcinoma treated in a phase II clinical trial http://http://www.bioalliancepharma.com/eng/content/download/5324/59614/version/1/file/0911208EN_DoxoTransdrug.pdf 23 November 2009 - BioAlliance Pharma presents efficacy and safety preclinical results for its AMEP™ anti-invasive biotherapy at the ESGCT Annual Congress in Hannover, November 21 to 25, 2009 http://http://www.bioalliancepharma.com/eng/content/download/5146/57331/version/1/file/091123EN_AmepESGCT.pdf 19 November 2009 - BioAlliance Pharma ranked as France's fastest growing company in the "2009 Deloitte Technology Fast 50™" http://http://www.bioalliancepharma.com/eng/content/download/5091/56649/version/1/file/091119EN_Deloitte.pdf 12 November 2009 - BioAlliance Pharma presents results for its new oral chemotherapy nanoparticle innovation at the AAPS Annual Meeting in Los Angeles, November 8 to 12, 2009 http://http://www.bioalliancepharma.com/eng/content/download/5037/55993/version/1/file/091112EN_AAPS.pdf 05 November 2009 - Epidemiological study on Oropharyngeal Candidiasis and results on miconazole MBT compliance were presented at the 51st ASTRO Annual Meeting http://http://www.bioalliancepharma.com/eng/content/download/4982/55348/version/1/file/091105EN_ ASTRO.pdf 04 November 2009 - BioAlliance Pharma presents additional US pivotal Phase III results on LoramycTM (miconazole Lauriad®) at the 47th Annual Meeting of the IDSA http://http://www.bioalliancepharma.com/eng/content/download/4972/55231/version/1/file/091104EN_ IDSA.pdf 21 October 2009 - Two new appointments to BioAlliance Pharma's Supervisory Board in phase with the Company's development http://http://www.bioalliancepharma.com/eng/content/download/4846/53657/version/1/file/091021EN_CooptationsCS.pdf 21 October 2009 - Q3 2009: Strong Sales Growth and Significant Progress in Clinical Development http://http://www.bioalliancepharma.com/eng/content/download/4844/53651/version/1/file/091021EN_Q32009.pdf 12 October 2009 - BioAlliance Pharma announces Phase I trial for Fentanyl Lauriad® and the submission of a Clonidine Lauriad® Phase II clinical trial application http://http://www.bioalliancepharma.com/eng/content/download/4740/52348/version/1/file/091012EN_Fentanyl Clonidine.pdf 22 September 2009 - BioAlliance Pharma announces that the civil action filed by Eurofins in the United States is rejected http://http://www.bioalliancepharma.com/eng/content/download/4591/50463/version/1/file/0909122EN_Eurofins US.pdf 15 September 2009 - BioAlliance Pharma makes four presentations at the 49th ICAAC Meeting including three phase III study results with miconazole Lauriad® and one with its integrase inhibitor http://http://www.bioalliancepharma.com/eng/content/download/4529/49680/version/1/file/090915EN_ ICAAC.pdf 07 September 2009 - BioAlliance Pharma announces participation in the MidCap Event on September 21 and 22, 2009 http://http://www.bioalliancepharma.com/eng/content/download/4484/49133/version/1/file/090907EN_Midcapevent.pdf 28 August 2009 - BioAlliance Pharma to present at the French-Norwegian Interdisciplinary Symposium on Nano and Micro Frontiers in Biology and Medicine (Bergen, Norway, August 31 to September 2, 2009) http://http://www.bioalliancepharma.com/eng/content/download/4416/48272/version/1/file/090828EN_French-Norwegian symposium.pdf 26 August 2009 - Consolidated accounts for the first half of 2009 http://http://www.bioalliancepharma.com/eng/content/download/4384/47949/version/1/file/090826EN_Comptes semestriels 2009.pdf